Controlled delivery of drugs through smart pH-sensitivenanohydrogels for anti-cancer therapies: synthesis, drug release and cellular studies

A. Alvarez-Bautista*, C. M. M. Duarte, E. Mendizabal, I. Katime

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Nanohydrogels were synthesized by microemulsion polymerization. These nanohydrogels were pre-designed to be pH and temperature stimuli-response materials, using N-isopropylacrilamide as a base monomer and 1-vinyl imidazole as ionizable comonomer. The pH sensitivity was confirmed by measuring the increase or decrease in volume in the nanoparticles by changing the pH of the medium. Nanoparticles were properly characterized by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), nuclear magnetic resonance (NMR) and transmission electron microscopy (TEM). Glass-transition temperature increased with vinyl imidazole content, and nanoparticles with average diameter of 68nm were obtained. Particle size decreases with the increase in pH. After characterization, nanohydrogels were functionalized with folic acid to take advantage that the folate receptor is overexpressed in different types of cancer cells. The nanoparticles were loaded with the drugs: metformin, terfenadine, and 5-fluorouracil. The amount of drug loaded and released by nanoparticles was measured by UV-vis spectroscopy. Then, cellular viability and internalization studies were performed obtaining promising results.

Original languageEnglish
Pages (from-to)319-329
Number of pages11
JournalDesigned Monomers and Polymers
Volume19
Issue number4
DOIs
StatePublished - May 18 2016
Externally publishedYes

Keywords

  • Delivery
  • cancer cells
  • nanohydrogels
  • nanoparticles
  • smart nanocarriers
  • POLY(DIVINYLBENZENE) MICROSPHERES
  • MICROGELS
  • POLYMERIZATION
  • ACID

Fingerprint

Dive into the research topics of 'Controlled delivery of drugs through smart pH-sensitivenanohydrogels for anti-cancer therapies: synthesis, drug release and cellular studies'. Together they form a unique fingerprint.

Cite this